Item 2.02  Results of Operations and Financial Condition.
On November 9, 2020, Kindred Biosciences, Inc. ("KindredBio") issued a press
release announcing its financial results for the three months ended September
30, 2020 and recent business developments. A copy of the press release is
attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated
herein by reference.
The information furnished under this Item 2.02, including the accompanying
Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18
of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise
subject to the liability of such section, nor shall such information be deemed
to be incorporated by reference in any subsequent filing by KindredBio under the
Securities Act of 1933 or the Exchange Act, regardless of the general
incorporation language of such filing, except as specifically stated in such
filing.
Item 9.01  Financial Statements and Exhibits.
(d)  Exhibits
Exhibit No.                 Description
        99.1                  Press Release of Kindred Biosciences, Inc. issued on November 9,
                            2020.
        104                 Cover Page Interactive Data File (embedded within the Inline XBRL
                            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses